Abstract:BACKGROUND: Ferroptosis is a brand-new type of controlled cell death that is distinguished by its reliance on iron and the production of lipid peroxidation. The role of ferroptosis in damaging liver disorders has attracted a lot of attention in recent years. One effective strategy to reduce liver damage is to target ferroptosis.PURPOSE: The purpose of this review is to clarify the connection between ferroptosis and liver damage and to look into the potential contribution of natural products to the clinical management of liver damage and the discovery of novel medications.METHODS: To study the methods by which natural products operate on ferroptosis to cure liver damage and their main signaling pathways, we searched databases from the time of initial publication to August 2023 in PubMed, EMBASE, Web of Science, Ovid, ScienceDirect, and China National Knowledge Infrastructure. The liver illness that each natural product treats is categorized and summarized. It's interesting to note that several natural compounds, such Artemether, Fucoidan sulfate, Curcumin, etc., have the benefit of having many targets and multiple pathways of action.RESULTS: We saw that in human samples or animal models of liver injury, ferroptosis indicators were activated, lipid peroxidation levels were elevated, and iron inhibitors had the ability to reduce liver damage. Liver damage can be treated with natural products by regulating ferroptosis. This is mostly accomplished through the modulation of Nrf2-related pathways (e.g., Conclusions and Astaxanthin), biological enzymes like GPX4 and the SIRT family (e.g., Chrysophanol and Decursin), and transcription factors like P53 (e.g., Artemether and Zeaxanthin).CONCLUSIONS: This review proposes a promising path for the therapeutic therapy of liver damage by providing a theoretical foundation for the management of ferroptosis utilizing natural ingredients.

Targeting ferroptosis, a novel programmed cell death, for the potential of alcohol-related liver disease therapy

Ferroptosis is Involved in Alcohol-Induced Cell Death in Vivo and in Vitro.

Ferroptosis and Renal Fibrosis: A New Target for the Future (Review)

Targeting Ferroptosis in Breast Cancer

Ferroptosis contributes to ethanol-induced hepatic cell death via labile iron accumulation and GPx4 inactivation

Ferroptosis as a new therapeutic opportunity for nonviral liver disease.

Exploring the Updated Roles of Ferroptosis in Liver Diseases: Mechanisms, Regulators, and Therapeutic Implications

Targeting Ferroptosis for Cancer Therapy: Exploring Novel Strategies from Its Mechanisms and Role in Cancers

Role of Ferroptosis in ALD: Focusing on Hepcidin and Besides Hepcidin

Targeting ferroptosis with natural products in liver injury: new insights from molecular mechanisms to targeted therapies

Ferroptosis in liver disease: new insights into disease mechanisms

Ferroptosis: Shedding Light on Mechanisms and Therapeutic Opportunities in Liver Diseases

Ferroptosis as an emerging therapeutic target in liver diseases

Role of Ferroptosis in Non-Alcoholic Fatty Liver Disease and Its Implications for Therapeutic Strategies

The Emerging Role of Ferroptosis in Liver Diseases

Ferroptosis in Chronic Liver Diseases: Opportunities and Challenges

Targeting Ferroptosis As a Potential Prevention and Treatmentstrategy for Human Diseases

Research mechanisms of and pharmaceutical treatments for ferroptosis in liver diseases

Targeting Ferroptosis for Lung Diseases: Exploring Novel Strategies in Ferroptosis-Associated Mechanisms

Ferroptosis in Liver Disease: Natural Active Compounds and Therapeutic Implications

Ferroptosis and Drug-Induced Liver Injury